ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO0642

Estrogen-Related Receptor Gamma Identified as a Novel Link Between Ciliogenesis and Nephron Development

Session Information

Category: Development, Stem Cells, and Regenerative Medicine

  • 500 Development, Stem Cells, and Regenerative Medicine

Authors

  • Weselman, Hannah M., University of Notre Dame Department of Biological Sciences, Notre Dame, Indiana, United States
  • Wingert, Rebecca A., University of Notre Dame Department of Biological Sciences, Notre Dame, Indiana, United States
Background

Aberrant formation of cilia, hair-like projections that facilitate mechano- and chemo-sensing, has been linked to developmental disorders, kidney dysfunction, and renal cyst formation. Since prostaglandin signaling has been noted as a key regulator of ciliogenesis, we investigated potential upstream factors that could contribute to both kidney and cilia development. One nuclear receptor, Esrrγ, was of particular interest, as it interacts with known ciliogenic factors and causes renal cysts in mouse knockout models.

Methods

We confirmed that Esrrγ does indeed affect endogenous prostaglandin levels through an ELISA assay of Esrrγ deficiency models. We also assessed the effect of Esrrγ deficiency using whole mount in situ hybridization to characterize changes in distinct nephron cell populations. We used immunohistochemistry to quantify aberrant cilia formation, cell polarity, and cell turnover in the kidney, ear, and node. We utilized qRT-PCR to measure changes in transcription of potential downstream targets, and used overexpression or chemical treatments to rescue with these targets or their products to further support regulatory relationships.

Results

Esrrγ deficient embryos had decreased endogenous PGE2 levels and exhibited nephron composition defects including expanded expression of proximal markers and reduced distal segments. These were likely due to changes in cell fate choice, as no changes in cell death or proliferation were found. The formation of renal cilia was also disrupted, where both cilia length and number of ciliated basal bodies were significantly reduced in ciliated cell populations. Interestingly, Esrrγ was required for ciliogenesis in other tissues as well, as cilia length was also decreased in the node and the ear. These phenotypes were consistent with a disruption of prostaglandin signaling, and we found that expression of the prostaglandin cyclooxygenase enzyme (Cox1) and prostaglandin regulator Pgc1a was reduced in Esrrγ deficient embryos. Treatment with dmPGE2 or Cox1 overexpression was sufficient to rescue renal and cilia defects.

Conclusion

These data position Esrrγ as a novel link between ciliogenesis and nephrogenesis through regulation of prostaglandin signaling, and highlight Esrrγ as a potential new target for future ciliopathic treatments.